PUBLISHER: The Business Research Company | PRODUCT CODE: 2111482
PUBLISHER: The Business Research Company | PRODUCT CODE: 2111482
Minimally invasive robotic surgical systems refer to advanced medical technologies that integrate robotics, precision instruments, imaging systems, and control software to assist surgeons in performing complex surgical procedures through small incisions. These systems are designed to enhance surgical accuracy, reduce human error, improve dexterity, and minimize patient trauma, leading to faster recovery times and improved clinical outcomes.
The primary product types of minimally invasive robotic surgical system include multi-port robotic surgical systems, single-port robotic surgical systems, modular robotic platforms, and table-mounted robotic systems. Multi-port robotic surgical systems refer to advanced surgical platforms that use multiple robotic arms and entry points to perform precise and minimally invasive procedures. These systems are categorized by procedure type including soft tissue surgery, hard tissue surgery, laparoscopic robotic-assisted procedures, and percutaneous or catheter-based robotic procedures. The key applications include general surgery, urology, gynecology, orthopedic surgery, cardiothoracic surgery, and neurosurgery, while the end-users include hospitals, ambulatory surgical centers, specialty surgical clinics, and academic and research institutes.
Tariffs are influencing the minimally invasive robotic surgical systems market by increasing the cost of imported robotic platforms, precision surgical instruments, imaging modules, and semiconductor-based control systems required for advanced surgical procedures. This is slowing procurement and deployment of robotic surgery systems across hospitals and ambulatory surgical centers, particularly in import-dependent regions such as Asia-Pacific and Latin America. Hardware-intensive segments like multi-port robotic surgical systems, modular robotic platforms, and integrated imaging surgical systems are most affected due to high global supply chain dependency. However, tariffs are also encouraging localization of manufacturing, development of regional supplier ecosystems, and increased investment in domestic medical device production, strengthening long-term supply chain resilience in the market.
The minimally invasive robotic surgical system market size has grown rapidly in recent years. It will grow from $8.9 billion in 2025 to $10.25 billion in 2026 at a compound annual growth rate (CAGR) of 15.1%. The growth in the historic period can be attributed to rising adoption of laparoscopic surgery demand, increasing hospital investment in advanced surgical infrastructure, growing prevalence of chronic diseases requiring surgery, shortage of skilled surgeons in complex procedures, early adoption of robotic assisted surgical systems.
The minimally invasive robotic surgical system market size is expected to see rapid growth in the next few years. It will grow to $18.15 billion in 2030 at a compound annual growth rate (CAGR) of 15.4%. The growth in the forecast period can be attributed to expansion of outpatient and ambulatory surgical centers usage, increasing healthcare reimbursement for robotic procedures, growth in precision medicine driven surgical planning, rising demand for minimally invasive cosmetic and elective surgeries, technological convergence in hybrid operating rooms. Major trends in the forecast period include haptic feedback enhanced surgical precision systems, advanced intraoperative imaging fusion and navigation accuracy, miniaturized precision surgical instrument development for micro incisions, operating room workflow integration and robotic system compatibility, enhanced sterilization, maintenance and infection control protocols for robotic platforms.
The increasing preference for minimally invasive procedures is expected to propel the growth of the minimally invasive robotic surgical system market going forward. Minimally invasive procedures refer to medical techniques performed through small incisions or natural body openings that reduce tissue damage, pain, and recovery time compared to traditional open surgery. Preference for minimally invasive procedures is rising due to increasing awareness of aesthetic enhancement options, along with a strong demand for safer treatments that offer minimal downtime, fewer risks, and quicker visible results. Minimally invasive robotic surgical systems enable minimally invasive procedures by providing enhanced precision, improved visualization, and highly controlled instrument movements that allow complex surgeries to be performed through small incisions with reduced tissue damage, less pain, and faster recovery. For instance, in June 2024, according to the American Society of Plastic Surgeons, a US-based non-profit organization, liposuction procedures reached a total of 347,782 in 2023, representing a 7% increase compared to 2022, while minimally invasive procedures also grew by 7% during the same period, outpacing the growth of surgical procedures by 2%. Therefore, the increasing preference for non-invasive cosmetic procedures is driving the growth of the minimally invasive robotic surgical system market.
Major companies operating in the minimally invasive robotic surgical system market are focusing on developing innovative systems, such as next-generation robotic-assisted surgical systems, to enhance surgical precision, improve patient outcomes, and reduce recovery time. Next-generation robotic-assisted surgical systems are advanced computer-controlled platforms that help surgeons perform minimally invasive procedures with greater precision, stability, and control by using robotic arms, high-definition 3D visualization, and real-time motion scaling to translate surgeon movements into highly accurate surgical actions. For instance, in July 2025, Aster MIMS Calicut, an India-based healthcare provider, introduced North Kerala's first Da Vinci Xi Robotic Surgical System, marking a significant advancement in its robotic surgery capabilities and establishing an advanced centre for robotic surgery. The Da Vinci Xi system is an advanced robotic-assisted surgical platform designed to enhance surgeon control, precision, and ergonomics during complex procedures, featuring robotic arms, a surgeon console, and a high-definition vision system that delivers magnified, 3D views of the surgical field; it enables minimally invasive procedures with improved access to hard-to-reach anatomical areas while reducing blood loss and postoperative complications. It supports a wide range of surgical applications including urology, gynecology, general surgery, and oncology, making it highly versatile across multiple specialties and improving procedural consistency and safety.
In October 2025, Zimmer Biomet Holdings Inc., a US-based medical technology company, acquired Monogram Technologies Inc. for an undisclosed amount. With this acquisition, Zimmer Biomet Holdings Inc. aimed to strengthen its orthopedic robotics portfolio by integrating Monogram Technologies Inc.'s AI-enabled, CT-based semi- and fully autonomous robotic systems, thereby accelerating its roadmap toward next-generation autonomous surgical solutions for joint replacement procedures and expanding its digital and robotic surgery ecosystem. Monogram Technologies Inc. is a US-based medical technology company that specializes in developing AI-driven, CT-based robotic systems for orthopedic surgery, including semi-autonomous and fully autonomous technologies designed to improve precision and outcomes in total knee arthroplasty procedures.
Major companies operating in the minimally invasive robotic surgical system market are Intuitive Surgical Inc.; Johnson & Johnson; Medtronic plc; Stryker Corporation; Zimmer Biomet Holdings Inc.; Smith & Nephew plc; Globus Medical Inc.; MicroPort MedBot (Group) Co. Ltd.; PROCEPT BioRobotics Corporation; Medicaroid Corporation; Brainlab AG; Siemens Healthineers; CMR Surgical Ltd.; Distalmotion SA; Vicarious Surgical Inc.; Virtual Incision Corporation; Ronovo Surgical Inc.; Edge Medical Robotics Ltd.; Moon Surgical SAS; Neocis Inc.; EndoQuest Robotics.
North America was the largest region in the minimally invasive robotic surgical system market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the minimally invasive robotic surgical system market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the minimally invasive robotic surgical system market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The minimally invasive robotic surgical system market consists of sales of robotic arms, surgical consoles, imaging and navigation systems, end-effectors, simulation systems, and related surgical instruments and accessories. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
The minimally invasive robotic surgical system market research report is one of a series of new reports from The Business Research Company that provides minimally invasive robotic surgical system market statistics, including minimally invasive robotic surgical system industry global market size, regional shares, competitors with a minimally invasive robotic surgical system market share, detailed minimally invasive robotic surgical system market segments, market trends and opportunities, and any further data you may need to thrive in the minimally invasive robotic surgical system industry. This minimally invasive robotic surgical system market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Minimally Invasive Robotic Surgical System Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses minimally invasive robotic surgical system market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for minimally invasive robotic surgical system ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The minimally invasive robotic surgical system market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.